Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page's Revision value was updated from v3.5.3 to v3.5.4, indicating a minor update to the record's metadata or formatting rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-05-15T14:59:06.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a site build change without altering the displayed clinical trial study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:36:40.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:43.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 is displayed on the page. This change reflects a minor version update with no apparent impact on content or user actions.
    Difference
    0.0%
    Check dated 2026-03-19T06:19:24.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:20.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    New date stamps and results-posting status were added (e.g., 'No Results Posted' on 2026-03-03), and older entries were removed. The overall study details, eligibility criteria, and planned interventions remain unchanged.
    Difference
    0.2%
    Check dated 2026-03-05T00:22:09.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.